Premier Alternatives

Pearl Diagnostics

Baltimore, MD · Founded 2014 · Privately Held (backing)

Developer of in vitro diagnostic tests designed to aid diagnosis and screening for bacterial and fungal lung infections. Pearl Diagnostics is based in Baltimore, MD and was founded in 2014. Its last reported valuation was $15 million in Jun 2022. It has raised $4.5 million across 2 recorded rounds; the latest was an $11.2 million early-stage round in Mar 2026.

Last reported valuation
$15.0M
Oct 2026
Priced at
—
Total raised
$4.5M
Last round
Early Stage VC
Mar 2026

Pearl Diagnostics key facts

as of Oct 2026
  • Developer of in vitro diagnostic tests designed to aid diagnosis and screening for bacterial and fungal lung infections.
  • Pearl Diagnostics is valued at approximately $15.0M as of Oct 2026 (last reported valuation).
  • It has raised $4.5M across 2 recorded rounds; the latest was Early Stage VC ($11.2M) in Mar 2026.
  • Notable investors include Creative Destruction Lab, US National Science Foundation, TEDCO, CARB-X, John Cammack — 11 tracked in total.
  • Pearl Diagnostics has filed 2 Form Ds with the SEC since 2022, most recently Apr 2026 ($11.2M sold to 21 investors).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$15.0M

Pearl Diagnostics's last reported valuation, Jun 2022. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Pearl Diagnostics with a free account
  • ·The complete investor list: 11 names
  • ·Watch Pearl Diagnostics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Pearl Diagnostics funding rounds

2 rounds
Mar 2026Early Stage VC$11.2MSEC filing▮
Feb 2022Seed Round$3.5MSEC filing▮
Full funding history →

Pearl Diagnostics valuation

Pearl Diagnostics's last reported valuation was $15 million in Jun 2022. No priced round, secondary trade or fund mark has surfaced since.

How much has Pearl Diagnostics raised?

Pearl Diagnostics has raised $4.5 million across 2 recorded rounds since 2022. The largest was a $3.5 million seed round in Feb 2022; the most recent was an $11.2 million early-stage round in Mar 2026.

Pearl Diagnostics has filed 2 Form Ds with the SEC since 2022, most recently in Apr 2026 ($11.2 million sold to 21 investors).

Pearl Diagnostics investors

11 investors are on record for Pearl Diagnostics, including Creative Destruction Lab, US National Science Foundation, TEDCO and CARB-X. The early-stage round in Mar 2026 drew 21 investors.

About Pearl Diagnostics

Developer of in vitro diagnostic tests designed to aid diagnosis and screening for bacterial and fungal lung infections. The company uses proprietary and patented technology to detect microbial vesicles that are released during infection and excreted into urine, and detect fungal lung infections using interferon-gamma release technologies, enabling clinicians to detect the microbial cause of pneumonia using patented technology.

Sector
Healthcare
HQ
Baltimore, MD, United States
Founded
2014
Employees
9
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.